Association Between Osteopontin Gene Polymorphisms and Cerebral Palsy in a Chinese Population

NeuroMolecular Medicine

Volumn 18, Issue 2, 2016, Pages 232-238

  Shang, Qing ^a   Zhou, Chongchen ^a   Liu, Dongzhi ^a   Li, Wenxia ^a   Chen, Mingjie ^b   Xu, Yiran ^c   Wang, Fei ^c   Bi, Dan ^c   Zhang, Xiaoli ^c   Zhao, Xinzhi ^b   Wang, Lei ^b   Zhu, Changlian ^c,d   Xing, Qinghe ^b  

^a Department of Pediatric Surgery Zhengzhou Children s Hospital   (China)

^b FUDAN UNIVERSITY   (China)

^c ZHENGZHOU UNIVERSITY   (China)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Association; Cerebral palsy; Osteopontin; SNP

Indexed keywords

OSTEOPONTIN;

ARTICLE; CEREBRAL PALSY; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC PARAMETERS; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAN CHINESE; HAPLOTYPE; HARDY WEINBERG EQUILIBRIUM; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; OPN GENE; PRESCHOOL CHILD; PRIORITY JOURNAL; SAMPLE SIZE; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; CHINA; GENETIC PREDISPOSITION; GENETICS;

CASE-CONTROL STUDIES; CEREBRAL PALSY; CHINA; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; OSTEOPONTIN; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84964489827     PISSN: 15351084     EISSN: 15591174     Source Type: Journal    
DOI: 10.1007/s12017-016-8397-7     Document Type: Article

References (34)

1. Albertsson, A. M., Zhang, X., Leavenworth, J., Bi, D., Nair, S., Qiao, L., et al. (2014). The effect of osteopontin and osteopontin-derived peptides on preterm brain injury. Journal of Neuroinflammation, 11(1), 197.
2. Arjomandi, M., Galanter, J. M., Choudhry, S., Eng, C., Hu, D., Beckman, K., et al. (2011). Polymorphism in osteopontin gene (SPP1) is associated with asthma and related phenotypes in a Puerto Rican population. Pediatric allergy, immunology, and pulmonology, 24(4), 207–214.
3. Ashkar, S., Weber, G. F., Panoutsakopoulou, V., Sanchirico, M. E., Jansson, M., Zawaideh, S., et al. (2000). Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science, 287(5454), 860–864.
4. Bi, D., Chen, M., Zhang, X., Wang, H., Xia, L., Shang, Q., et al. (2014). The association between sex-related interleukin-6 gene polymorphisms and the risk for cerebral palsy. Journal of Neuroinflammation, 11, 100.
5. Bonestroo, H. J., Nijboer, C. H., van Velthoven, C. T., van Bel, F., & Heijnen, C. J. (2015). The neonatal brain is not protected by osteopontin peptide treatment after hypoxia-ischemia. Developmental Neuroscience, 37(2), 142–152.
6. Brown, A. (2012). Osteopontin: A key link between immunity, inflammation and the central nervous system. Translational Neuroscience, 3(3), 288–293.
7. Chen, M., Li, T., Lin, S., Bi, D., Zhu, D., Shang, Q., et al. (2013). Association of Interleukin 6 gene polymorphisms with genetic susceptibilities to spastic tetraplegia in males: a case-control study. Cytokine, 61(3), 826–830.
8. Costeff, H. (2004). Estimated frequency of genetic and nongenetic causes of congenital idiopathic cerebral palsy in west Sweden. Annals of Human Genetics, 68(Pt 5), 515–520.
9. Dammann, O. (2007). Persistent neuro-inflammation in cerebral palsy: A therapeutic window of opportunity? Acta Paediatrica, 96(1), 6–7.
10. Fan, Y., Zhang, X., Yang, Z. H., Sun, X. W., Li, S. N., Zhong, L., et al. (2013). The polymorphisms of osteopontin gene and plasma osteopontin protein levels with susceptibility to colorectal carcinoma. DNA and Cell Biology, 32(10), 594–600.
11. Fleiss, B., & Gressens, P. (2012). Tertiary mechanisms of brain damage: A new hope for treatment of cerebral palsy? Lancet Neurology, 11(6), 556–566.
12. Forton, A. C., Petri, M. A., Goldman, D., & Sullivan, K. E. (2002). An osteopontin (SPP1) polymorphism is associated with systemic lupus erythematosus. Human Mutation, 19(4), 459.
13. Gibson, C. S., Maclennan, A. H., Dekker, G. A., Goldwater, P. N., Sullivan, T. R., Munroe, D. J., et al. (2008). Candidate genes and cerebral palsy: A population-based study. Pediatrics, 122(5), 1079–1085.
14. Girard, S., Kadhim, H., Roy, M., Lavoie, K., Brochu, M. E., Larouche, A., & Sebire, G. (2009). Role of perinatal inflammation in cerebral palsy. Pediatric Neurology, 40(3), 168–174.
15. Glas, J., Seiderer, J., Bayrle, C., Wetzke, M., Fries, C., Tillack, C., et al. (2011). The role of osteopontin (OPN/SPP1) haplotypes in the susceptibility to Crohn’s disease. PLoS ONE, 6(12), e29309.
16. Hashimoto, M., Sun, D., Rittling, S. R., Denhardt, D. T., & Young, W. (2007). Osteopontin-deficient mice exhibit less inflammation, greater tissue damage, and impaired locomotor recovery from spinal cord injury compared with wild-type controls. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 27(13), 3603–3611.
17. Jan, M. M. (2006). Cerebral palsy: Comprehensive review and update. Annals of Saudi medicine, 26(2), 123–132.
18. Li, Z., Zhang, Z., He, Z., Tang, W., Li, T., Zeng, Z., et al. (2009). A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x.cn). Cell Research, 19(4), 519–523.
19. MacLennan, A. H., Thompson, S. C., & Gecz, J. (2015). Cerebral palsy: Causes, pathways, and the role of genetic variants. American Journal of Obstetrics and Gynecology, 213(6), 779–788.
20. Nelson, K. B., & Blair, E. (2015). Prenatal factors in singletons with cerebral palsy born at or near term. The New England Journal of Medicine, 373(10), 946–953.
21. Nelson, K. B., & Grether, J. K. (1999). Causes of cerebral palsy. Current Opinion in Pediatrics, 11(6), 487–491.
22. Nelson, K. B., & Willoughby, R. E. (2000). Infection, inflammation and the risk of cerebral palsy. Current Opinion in Neurology, 13(2), 133–139.
23. Rosenbaum, P., Paneth, N., Leviton, A., Goldstein, M., Bax, M., Damiano, D., et al. (2007). A report: The definition and classification of cerebral palsy April 2006. Developmental Medicine and Child Neurology. Supplement, 109, 8–14.
24. Safarinejad, M. R., Shafiei, N., & Safarinejad, S. (2013). Association between polymorphisms in osteopontin gene (SPP1) and first episode calcium oxalate urolithiasis. Urolithiasis, 41(4), 303–313.
25. Shi, Y. Y., & He, L. (2005). SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Research, 15(2), 97–98.
26. Surveillance of Cerebral Palsy in Europe (SCPE). (2000). Surveillance of cerebral palsy in Europe: A collaboration of cerebral palsy surveys and registers. Developmental Medicine and Child Neurology, 42(12), 816–824.
27. The Child Rehabilitation Committee of Chinese Rehabilitation Medical Association. (2007). The definition of cerebral palsy, classification and diagnosis. Chinese Journal of Physical Medicine and Rehabilitation, 29(5), 309.
28. Tollanes, M. C., Wilcox, A. J., Lie, R. T., & Moster, D. (2014). Familial risk of cerebral palsy: population based cohort study. BMJ, 349, g4294.
29. Tugcu, V., Simsek, A., Tarhan, T., Atalar, F., Bitkin, A., Tasci, A. I., et al. (2013). OPN gene polymorphism (Ala250) and lower serum OPN levels are associated with urolithiasis. Renal Failure, 35(6), 825–829.
30. van Velthoven, C. T., Heijnen, C. J., van Bel, F., & Kavelaars, A. (2011). Osteopontin enhances endogenous repair after neonatal hypoxic-ischemic brain injury. Stroke, 42(8), 2294–2301.
31. Wang, P. H., Liu, Y. F., Tsai, H. T., Tee, Y. T., Lin, L. Y., Hsieh, Y. H., & Yang, S. F. (2010). Elevated plasma osteopontin level is associated with pelvic inflammatory disease. Reproductive sciences, 17(11), 1052–1058.
32. Wang, H., Xu, Y., Chen, M., Shang, Q., Sun, Y., Zhu, D., et al. (2013). Genetic association study of adaptor protein complex 4 with cerebral palsy in a Han Chinese population. Molecular Biology Reports, 40(11), 6459–6467.
33. Wu, Y. W., Croen, L. A., Torres, A. R., Van De Water, J., Grether, J. K., & Hsu, N. N. (2009). Interleukin-6 genotype and risk for cerebral palsy in term and near-term infants. Annals of neurology, 66(5), 663–670.
34. Wu, Y. W., Escobar, G. J., Grether, J. K., Croen, L. A., Greene, J. D., & Newman, T. B. (2003). Chorioamnionitis and cerebral palsy in term and near-term infants. JAMA, 290(20), 2677–2684.